Janus Henderson Group PLC Royalty Pharma PLC Transaction History

Janus Henderson Group PLC

$174 Billion
Q1 2025

A detailed history of Janus Henderson Group PLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Janus Henderson Group PLC holds 34,237 shares of RPRX stock, worth $1.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,237

Previous 34,237 -0.0%

Holding current value

$1.15 Million

Previous $873,000 21.99%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$24.28 - $28.39 $42 Million - $49.1 Million	-1,729,008 Reduced 98.06%	34,237 $873,000
Q3 2024 Nov 14, 2024	SELL	$25.63 - $29.27 $106,928 - $122,114	-4,172 Reduced 0.24%	1,763,245 $49.9 Million
Q2 2024 Aug 14, 2024	SELL	$26.26 - $29.9 $2.24 Million - $2.55 Million	-85,243 Reduced 4.6%	1,767,417 $46.6 Million
Q1 2024 May 15, 2024	SELL	$27.46 - $31.33 $1.32 Million - $1.5 Million	-47,954 Reduced 2.52%	1,852,660 $56.3 Million
Q4 2023 Feb 14, 2024	SELL	$26.21 - $29.22 $8.8 Million - $9.81 Million	-335,782 Reduced 15.01%	1,900,614 $53.4 Million
Q3 2023 Nov 14, 2023	SELL	$26.26 - $31.38 $990,107 - $1.18 Million	-37,704 Reduced 1.66%	2,236,396 $60.7 Million
Q2 2023 Aug 14, 2023	SELL	$29.6 - $36.56 $8.58 Million - $10.6 Million	-289,895 Reduced 11.31%	2,274,100 $69.9 Million
Q1 2023 May 15, 2023	SELL	$32.77 - $39.4 $1.2 Million - $1.44 Million	-36,506 Reduced 1.4%	2,563,995 $92.4 Million
Q4 2022 Feb 14, 2023	SELL	$39.17 - $44.04 $6.41 Million - $7.2 Million	-163,580 Reduced 5.92%	2,600,501 $103 Million
Q3 2022 Nov 14, 2022	SELL	$39.88 - $44.65 $13.7 Million - $15.3 Million	-342,520 Reduced 11.03%	2,764,081 $111 Million
Q2 2022 Aug 15, 2022	BUY	$37.53 - $44.22 $12.2 Million - $14.3 Million	323,775 Added 11.63%	3,106,601 $131 Million
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $7.97 Million - $9.02 Million	212,647 Added 8.27%	2,782,826 $108 Million
Q4 2021 Feb 14, 2022	BUY	$35.17 - $42.48 $7.31 Million - $8.83 Million	207,885 Added 8.8%	2,570,179 $102 Million
Q3 2021 Nov 16, 2021	SELL	$36.14 - $42.24 $50 Million - $58.4 Million	-1,383,120 Reduced 36.93%	2,362,294 $85.4 Million
Q2 2021 Aug 16, 2021	BUY	$39.85 - $46.63 $99.8 Million - $117 Million	2,505,360 Added 202.04%	3,745,414 $154 Million
Q1 2021 May 17, 2021	SELL	$42.34 - $52.82 $155 Million - $193 Million	-3,661,646 Reduced 74.7%	1,240,054 $54.1 Million
Q4 2020 Feb 16, 2021	BUY	$36.12 - $50.05 $6.4 Million - $8.86 Million	177,056 Added 3.75%	4,901,700 $245 Million
Q3 2020 Nov 16, 2020	BUY	$38.56 - $48.36 $8.39 Million - $10.5 Million	217,506 Added 4.83%	4,724,644 $199 Million
Q2 2020 Aug 14, 2020	BUY	$44.5 - $52.11 $201 Million - $235 Million	4,507,138 New	4,507,138 $219 Million

Others Institutions Holding RPRX

# of Institutions

484

Shares Held

283M

Call Options Held

2.51M

Put Options Held

941K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $14.7B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Royalty Pharma PLC Transaction History